Insider trades

Yeleswaram Krishnaswamy

Yeleswaram Krishnaswamy made 0 buys and 9 sales on the open market in the last 12 months at Rapport Therapeutics, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Chief Development Officer196KAug 25, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Aug 25, 2026Sale16,201US$51.06US$827K196KAug 26, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Aug 25, 2026Sale20,799US$50.31US$1.05M212KAug 26, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Aug 24, 2026Sale13,160US$50.00US$658K233KAug 26, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Aug 19, 2026Sale404US$49.90US$20,160246KAug 20, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Apr 17, 2026Sale20,225US$39.99US$809K246KApr 21, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Apr 14, 2026Sale10,200US$35.08US$358K267KApr 14, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Apr 13, 2026Sale9,165US$34.97US$321K277KApr 14, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Apr 10, 2026Sale500US$34.98US$17,490286KApr 14, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
Apr 8, 2026Sale360US$34.90US$12,564287KApr 9, 2026